KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Guardant Health (GH) Return on Equity (2018 - 2025)

Guardant Health's Return on Equity history spans 8 years, with the latest figure at 1.83% for Q4 2025.

  • For Q4 2025, Return on Equity fell 253.0% year-over-year to 1.83%; the TTM value through Dec 2025 reached 1.83%, down 253.0%, while the annual FY2025 figure was 3.48%, 4933.0% up from the prior year.
  • Return on Equity for Q4 2025 was 1.83% at Guardant Health, up from 1.21% in the prior quarter.
  • Across five years, Return on Equity topped out at 16.61% in Q3 2024 and bottomed at 85.08% in Q1 2023.
  • The 5-year median for Return on Equity is 0.62% (2022), against an average of 4.82%.
  • The largest annual shift saw Return on Equity plummeted -8440bps in 2023 before it skyrocketed 8102bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.57% in 2021, then tumbled by -915bps to 5.77% in 2022, then soared by 57bps to 2.48% in 2023, then surged by 276bps to 4.37% in 2024, then crashed by -58bps to 1.83% in 2025.
  • Per Business Quant, the three most recent readings for GH's Return on Equity are 1.83% (Q4 2025), 1.21% (Q3 2025), and 1.49% (Q2 2025).